Found 36 matching trials
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer NA RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
The Trial Comparing Dose-dense AC-T With TP as Adjuvant Therapy for TNBC With Homologous Recombination Repair Deficiency PHASE3 The purpose of this trial is to compare the 3-year disease-free survival of...
Show More Location
National Cancer Center, Cancer Hospital/Chinese Academy of Medical Sciences and Peking Union Medical College
Learn More & Join Trial
Dose Dense Doxorubucin and Cyclophosphamide Followed by Eribulin Mesylate for the Adjuvant Treatment of Early Stage Breast Cancer PHASE2 The purpose of this study is to assess the feasibility of dose-dense doxoru...
Show More Location
Dartmouth-Hitchcock Medical Center ,Norris Cotton Cancer Center
Learn More & Join Trial
Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Positive Breast Cancer PHASE3 RATIONALE: Drugs used in chemotherapy, such as docetaxel, doxorubicin , cyc...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial
Neoadjuvant MEDI4736 Concomitant With Weekly Nab-paclitaxel and Dose-dense AC for Stage I-III Triple Negative Breast Cancer PHASE1 The purpose of the study is to address the following hypotheses: (i) Anti-P...
Show More Location
Yale School of Medicine
Learn More & Join Trial
A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer PHASE2 The purpose of this study is to find out if it is practical (feasible) to g...
Show More Location
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer PHASE3 The primary objective of this trial is to compare the rate of pathologicall...
Show More Location
German Breast Group
Learn More & Join Trial
Phase II Study of Dose-Dense Doxurubicin and Cyclophosphamide (AC) Followed By Paclitaxel With Trastuzumab in HER2/ NEU-Amplified Breast Cancer: Feasibility PHASE2 HER-2/neu (+) breast cancer is a more aggressive form of breast cancer. HER...
Show More Location
Memorial Sloan Kettering Cancer Center
Learn More & Join Trial
Trial of Eribulin Followed by Doxorubicin & Cyclophosphamide for Her2-negative, Locally Advanced Breast Cancer PHASE2 Previous studies have shown that chemotherapy has the same effect on treati...
Show More Location
Grady Memorial Hospital
Learn More & Join Trial
Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer PHASE1 In this trial, the safety of combination treatment of Adriamycin plus cyclo...
Show More Location
Abraxis BioScience Inc.
Learn More & Join Trial